Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18885331 | DETECTION OF METHYLATION STATUS OF A DNA SAMPLE | September 2024 | May 2025 | Allow | 8 | 1 | 1 | Yes | No |
| 18673376 | METHOD FOR SCREENING LACTOBACILLUS CASEI FERMENTATION AGENT | May 2024 | October 2024 | Allow | 5 | 1 | 0 | No | No |
| 18576506 | METHOD FOR COLD PLASMA INDUCED CELL DEATH IN BREAST CANCER CELLS BY 8-OXOG MODIFICATION AND DEGRADATION OF HISTONE MRNA | January 2024 | May 2025 | Allow | 16 | 2 | 0 | No | No |
| 18330279 | METHODS FOR ASSEMBLING AND READING NUCLEIC ACID SEQUENCES FROM MIXED POPULATIONS | June 2023 | October 2024 | Abandon | 16 | 2 | 0 | No | No |
| 18173060 | SPECIFIC DNA FRAGMENT OF FEMALE ACIPENSER DABRYANUS AND METHOD FOR IDENTIFYING THE SEX OF ACIPENSER DABRYANUS | February 2023 | May 2024 | Allow | 27 | 2 | 0 | No | No |
| 17293412 | ELECTRONIC DETECTION OF NUCLEIC ACID STRUCTURE | September 2022 | July 2025 | Allow | 50 | 0 | 0 | No | No |
| 17864913 | LABELING STRATEGY FOR USE IN DNA SEQUENCING TO FACILITATE ASSEMBLY OF SEQUENCE READS INTO LONGER FRAGMENTS OF A GENOME | July 2022 | May 2025 | Allow | 34 | 1 | 0 | No | No |
| 17824215 | METHODS AND PROBES FOR PERFORMING PCR WITH MELT ANALYSIS FOR INCREASED MULTIPLEXING | May 2022 | January 2025 | Allow | 32 | 0 | 0 | No | No |
| 17735904 | Estimating Tumor Purity From Single Samples | May 2022 | September 2024 | Allow | 29 | 1 | 0 | Yes | No |
| 17731006 | Nucleic Acid Taggants | April 2022 | February 2025 | Allow | 33 | 2 | 0 | Yes | No |
| 17728463 | METHODS FOR STANDARDIZED SEQUENCING OF NUCLEIC ACIDS AND USES THEREOF | April 2022 | July 2025 | Allow | 38 | 1 | 0 | No | No |
| 17700373 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | March 2022 | September 2024 | Allow | 30 | 6 | 0 | No | No |
| 17651225 | NANOPORE-BASED POLYMER ANALYSIS WITH MUTUALLY-QUENCHING FLUORESCENT LABELS | February 2022 | November 2024 | Abandon | 33 | 1 | 0 | No | No |
| 17630004 | POLYNUCLEOTIDES FOR THE AMPLIFICATION AND DETECTION OF NEISSERIA GONORRHOEAE | January 2022 | April 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17575914 | DETECTING NUCLEIC ACID | January 2022 | December 2024 | Abandon | 35 | 1 | 0 | No | No |
| 17568077 | METHODS AND COMPOSITIONS FOR STABILIZING NUCLEIC ACID-NUCLEOTIDE-POLYMERASE COMPLEXES | January 2022 | May 2025 | Allow | 40 | 1 | 0 | No | No |
| 17562346 | Small RNA Capture, Detection and Quantification | December 2021 | May 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17547920 | DEVICES, SYSTEMS AND METHODS FOR BIOMARKER ANALYSIS | December 2021 | December 2023 | Abandon | 24 | 3 | 0 | Yes | No |
| 17531270 | SYSTEMS AND PROCESSES FOR DISTINGUISHING PATHOGENIC AND NON-PATHOGENIC SEQUENCES FROM SPECIMENS | November 2021 | April 2025 | Allow | 41 | 1 | 0 | No | No |
| 17529082 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | November 2021 | June 2024 | Allow | 31 | 5 | 0 | No | No |
| 17599423 | Shape-Responsive Nanostructures | September 2021 | January 2025 | Allow | 40 | 1 | 0 | No | No |
| 17470828 | PCR TUBE, APPARATUS FOR PCR INCLUDING THE SAME AND PCR METHOD USING THE SAME | September 2021 | November 2024 | Allow | 38 | 1 | 0 | No | No |
| 17458995 | NUCLEIC ACID ANALYSIS BY JOINING BARCODED POLYNUCLEOTIDE PROBES | August 2021 | January 2025 | Allow | 41 | 1 | 0 | No | No |
| 17434293 | AN IMPROVED METHOD OF PREPARING CLINICAL SAMPLES FOR NUCLEIC ACID AMPLIFICATION | August 2021 | May 2025 | Allow | 44 | 1 | 0 | No | No |
| 17397280 | UNIVERSAL SANGER SEQUENCING FROM NEXT-GEN SEQUENCING AMPLICONS | August 2021 | November 2024 | Allow | 39 | 2 | 0 | No | No |
| 17427266 | MULTIPLEX PCR METHOD USING APTAMER | July 2021 | March 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17369834 | ANALYSIS OF A POLYNUCLEOTIDE VIA A NANOPORE SYSTEM | July 2021 | March 2025 | Allow | 44 | 1 | 0 | No | No |
| 17369796 | SEQUENCES FOR DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) OF MREJ TYPE XXI | July 2021 | March 2025 | Abandon | 44 | 2 | 0 | No | No |
| 17356402 | METHOD FOR DETECTING CHIKUNGUNYA VIRUS | June 2021 | February 2025 | Allow | 44 | 3 | 0 | Yes | No |
| 17346077 | NUCLEIC ACID ASSAYS USING CLICK CHEMISTRY BIOCONJUGATION | June 2021 | September 2024 | Allow | 60 | 1 | 0 | No | No |
| 17336055 | OLIGONUCLEOTIDES AND BEADS FOR 5 PRIME GENE EXPRESSION ASSAY | June 2021 | July 2024 | Allow | 38 | 1 | 1 | No | No |
| 17316416 | METHOD FOR LABEL-FREE SINGLE-MOLECULE DNA SEQUENCING AND DEVICE FOR IMPLEMENTING SAME | May 2021 | December 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17289499 | Compositions and Methods for Discriminating Infectious from Non-Infectious CNS Disorders | April 2021 | November 2024 | Abandon | 42 | 0 | 1 | No | No |
| 17236889 | TERMINAL FUNCTIONALIZATION OF TARGET MOLECULES FOR SEQUENCING | April 2021 | December 2024 | Abandon | 44 | 2 | 0 | No | No |
| 17283968 | CATALYTIC BIOMOLECULE ACTIVITY RECORDING INTO DNA SEQUENCE | April 2021 | September 2024 | Allow | 42 | 1 | 0 | No | No |
| 17126693 | METHOD OF NONSPECIFIC TARGET CAPTURE OF NUCLEIC ACIDS | December 2020 | September 2024 | Allow | 45 | 4 | 1 | No | No |
| 17120518 | DETECTING CHOLANGIOCARCINOMA | December 2020 | August 2024 | Allow | 44 | 4 | 0 | Yes | No |
| 17070190 | Methods for Making Nucleotide Probes for Sequencing and Synthesis | October 2020 | August 2024 | Allow | 46 | 2 | 1 | No | No |
| 17046552 | DNA-TAGGED METHANOL RESPONSIVE POLYMER FOR SINGLE-STRANDED NUCLEIC ACID PRODUCTION | October 2020 | December 2023 | Allow | 38 | 3 | 0 | No | No |
| 17036401 | DETERMINISTIC BARCODING FOR SPATIAL OMICS SEQUENCING | September 2020 | July 2024 | Allow | 46 | 3 | 1 | No | No |
| 16979481 | METHODS OF SEQUENCING NUCLEIC ACIDS AND ERROR CORRECTION OF SEQUENCE READS | September 2020 | August 2024 | Allow | 47 | 4 | 0 | No | No |
| 16970318 | METHODS AND COMPOSITIONS FOR RICKETTSIACEAE DETECTION | August 2020 | April 2025 | Abandon | 56 | 3 | 1 | No | No |
| 16964386 | HYBRIDIZATION CHAIN REACTION-BASED METHOD FOR AMPLIFYING IMMUNOSIGNALS | July 2020 | November 2024 | Allow | 52 | 3 | 0 | No | No |
| 16869481 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID DETECTION | May 2020 | May 2025 | Abandon | 60 | 4 | 1 | No | No |
| 16628828 | HIGH-COVERAGE AND ULTRA-ACCURATE IMMUNE REPERTOIRE SEQUENCING USING MOLECULAR IDENTIFIERS | January 2020 | February 2025 | Abandon | 60 | 4 | 1 | Yes | No |
| 16596587 | SIMULTANEOUS QUANTIFICATION OF A PLURALITY OF PROTEINS IN A USER-DEFINED REGION OF A CROSS-SECTIONED TISSUE | October 2019 | June 2025 | Allow | 60 | 5 | 1 | Yes | No |
| 16444619 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | June 2019 | August 2024 | Allow | 60 | 4 | 1 | Yes | No |
| 16347387 | METHOD FOR DETERMINING A HEAD AND NECK SQUAMOUS CELL CARCINOMA | May 2019 | March 2025 | Allow | 60 | 5 | 1 | Yes | No |
| 15785680 | Low Sequence Bias Single-Stranded DNA Ligation | October 2017 | December 2019 | Allow | 26 | 1 | 0 | No | No |
| 15587944 | DETECTING NUCLEIC ACID | May 2017 | December 2019 | Allow | 31 | 1 | 0 | No | No |
| 15442864 | DNA SEQUENCING AND PROCESSING | February 2017 | August 2019 | Allow | 30 | 0 | 0 | Yes | No |
| 15285421 | Compositions And Methods For Immunodominant Antigens | October 2016 | August 2018 | Allow | 23 | 0 | 0 | No | No |
| 15271269 | REAL-TIME PCR POINT MUTATION ASSAYS FOR DETECTING HIV - 1 RESISTANCE TO ANTIVIRAL DRUGS | September 2016 | September 2019 | Allow | 35 | 2 | 1 | Yes | No |
| 15056475 | COMBINED THERMAL DEVICES FOR THERMAL CYCLING | February 2016 | November 2018 | Allow | 33 | 1 | 0 | No | No |
| 14931716 | EXOSOMES AND MICROVESICLES IN INTESTINAL LUMINAL FLUIDS AND STOOL AND USE OF SAME FOR THE ASSESSMENT OF INFLAMMATORY BOWEL DISEASE | November 2015 | December 2018 | Allow | 37 | 1 | 1 | No | No |
| 14765782 | METHOD FOR MEASURING BONE LOSS RATE | August 2015 | February 2018 | Allow | 30 | 2 | 0 | No | No |
| 14702628 | METHODS AND GENOTYPING PANELS FOR DETECTING ALLELES, GENOMES, AND TRANSCRIPTOMES | May 2015 | January 2018 | Allow | 32 | 0 | 0 | No | No |
| 14395239 | METHODS FOR REAL-TIME SAMPLING OF REACTION PRODUCTS | October 2014 | October 2017 | Allow | 36 | 1 | 1 | No | No |
| 14512694 | Digital Amplification | October 2014 | January 2018 | Allow | 39 | 1 | 1 | No | No |
| 14472155 | SPERM CELL SEPARATION METHODS AND COMPOSITIONS CONTAINING APTAMERS OR NUCLEIC ACID SEQUENCES FOR USE THEREIN | August 2014 | June 2016 | Allow | 22 | 1 | 0 | No | No |
| 14036527 | DOUBLE STRANDED LINEAR NUCLEIC ACID PROBE | September 2013 | March 2016 | Allow | 30 | 1 | 0 | Yes | No |
| 13748380 | DETECTION, IDENTIFICATION AND DIFFERENTIATION OF EUBACTERIAL TAXA USING A HYBRIDIZATION ASSAY | January 2013 | October 2015 | Allow | 33 | 2 | 0 | No | No |
| 13665566 | NOVEL MIXTURES FOR ASSAYING NUCLEIC ACID, NOVEL METHOD OF ASSAYING NUCLEIC ACID WITH THE USE OF THE SAME AND NUCLEIC ACID PROBE TO BE USED THEREFOR | October 2012 | October 2016 | Allow | 48 | 2 | 0 | No | Yes |
| 13466997 | METHODS, COMPOSITIONS AND KITS FOR DETECTION AND ANALYSIS OF ANTIBIOTIC-RESISTANT BACTERIA | May 2012 | June 2013 | Allow | 13 | 1 | 0 | Yes | No |
| 13389927 | STAPHYLOCOCCUS DETECTION ASSAYS | April 2012 | February 2016 | Allow | 48 | 1 | 1 | No | No |
| 13442514 | DEHALOGENASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | April 2012 | November 2015 | Allow | 43 | 3 | 0 | No | Yes |
| 13436465 | NUCLEIC ACID SEQUENCING TECHNIQUE USING A PH-SENSING AGENT | March 2012 | February 2016 | Allow | 47 | 2 | 1 | Yes | No |
| 13412984 | METHOD FOR DETECTING AND QUANTIFYING RARE MUTATIONS/POLYMORPHISMS | March 2012 | February 2016 | Allow | 48 | 3 | 0 | Yes | No |
| 13399543 | COMBINATORIAL AFFINITY SELECTION | February 2012 | June 2014 | Allow | 28 | 2 | 0 | No | No |
| 13229111 | DETECTION OF RNA-INTERACTING REGIONS IN DNA | September 2011 | July 2015 | Allow | 47 | 1 | 1 | No | No |
| 13229598 | METHODS, COMPOSITIONS AND KITS FOR DETECTION AND ANALYSIS OF ANTIBIOTIC-RESISTANT BACTERIA | September 2011 | March 2015 | Allow | 42 | 1 | 0 | No | No |
| 13205496 | METHODS, COMPOSITIONS AND KITS FOR DETECTION AND ANALYSIS OF ANTIBIOTIC-RESISTANT BACTERIA | August 2011 | June 2013 | Allow | 22 | 2 | 0 | Yes | No |
| 13178807 | METHODS, COMPOSITIONS AND KITS FOR DETECTION AND ANALYSIS OF ANTIBIOTIC-RESISTANT BACTERIA | July 2011 | September 2012 | Allow | 14 | 1 | 0 | No | No |
| 12997479 | EIF2GAMMA GENE AS A DIAGNOSTIC TARGET FOR THE IDENTIFICATION OF FUNGAL AND YEAST SPECIES | May 2011 | November 2017 | Allow | 60 | 4 | 0 | Yes | Yes |
| 13071105 | Digital Amplification | March 2011 | July 2014 | Allow | 39 | 3 | 1 | No | No |
| 13046186 | PARASITE DETECTION VIA ENDOSYMBIONT DETECTION | March 2011 | May 2017 | Allow | 60 | 6 | 1 | Yes | No |
| 12966583 | COMBINED THERMAL DEVICES FOR THERMAL CYCLING | December 2010 | April 2013 | Allow | 28 | 1 | 0 | No | No |
| 12945407 | METHOD FOR THE IDENTIFICATION AND QUANTIFICATION OF MICROORGANISMS USEFUL IN BIOMINING PROCESSES | November 2010 | March 2013 | Allow | 28 | 1 | 0 | No | No |
| 12742908 | METHODS AND SYSTEMS FOR BIOLOGICAL SAMPLE COLLECTION AND ANALYSIS | September 2010 | March 2014 | Allow | 46 | 2 | 1 | No | No |
| 12870568 | METHOD FOR DETECTING AN INDIVIDUAL WHO IS AFFLICTED WITH OR A CARRIER FOR VAN BUCHEM'S DISEASE | August 2010 | September 2011 | Allow | 13 | 1 | 0 | No | No |
| 12522480 | SLCO1B3 GENOTYPE | August 2010 | May 2018 | Allow | 60 | 8 | 0 | Yes | No |
| 12854619 | SPECIFIC DOUBLE-STRANDED PROBES FOR HOMOGENEOUS DETECTION OF NUCLEIC ACID AND THEIR APPLICATION METHODS | August 2010 | June 2015 | Allow | 59 | 5 | 0 | Yes | Yes |
| 12814199 | METHODS, COMPOSITIONS AND KITS FOR DETECTION AND ANALYSIS OF ANTIBIOTIC-RESISTANT BACTERIA | June 2010 | April 2013 | Allow | 34 | 1 | 0 | No | No |
| 12771042 | NON-TARGET AMPLIFICATION METHOD FOR DETECTION OF RNA SPLICE-FORMS IN A SAMPLE | April 2010 | June 2017 | Allow | 60 | 8 | 1 | No | No |
| 12738413 | METHOD OF NUCLEIC ACID AMPLIFICATION AND MEASURING REAGENT AND REAGENT KIT THEREFOR | April 2010 | June 2013 | Allow | 38 | 2 | 0 | Yes | No |
| 12677189 | NUCLEIC ACID DETECTION METHOD AND NUCLEIC ACID DETECTION KIT | March 2010 | March 2015 | Allow | 60 | 3 | 1 | No | No |
| 12706472 | PCR METHODS FOR CHARACTERIZING THE 5' UNTRANSLATED REGION OF THE FMR1 AND FMR2 GENES | February 2010 | October 2013 | Allow | 44 | 2 | 1 | No | No |
| 12700475 | REDUCING NON-TARGET NUCLEIC ACID DEPENDENT AMPLIFICATIONS: AMPLIFYING REPETITIVE NUCLEIC ACID SEQUENCES | February 2010 | June 2011 | Allow | 17 | 1 | 1 | No | No |
| 12683906 | DEHALOGENASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | January 2010 | December 2011 | Allow | 23 | 1 | 1 | Yes | No |
| 12617368 | DIGITAL AMPLIFICATION | November 2009 | December 2010 | Allow | 13 | 1 | 0 | No | No |
| 12614844 | MICRO VALVE APPARATUS USING MICRO BEAD AND METHOD FOR CONTROLLING THE SAME | November 2009 | April 2012 | Allow | 29 | 2 | 0 | No | No |
| 12551991 | FUNCTIONALIZED FLUORESCENT NANOCRYSTAL DETECTION SYSTEM | September 2009 | March 2012 | Allow | 31 | 2 | 0 | Yes | No |
| 12536269 | NANOSCALE SENSORS | August 2009 | February 2012 | Allow | 31 | 0 | 1 | Yes | No |
| 12458702 | ANNEALING CONTROL PRIMER AND ITS USES | July 2009 | October 2011 | Allow | 27 | 2 | 0 | No | No |
| 12504429 | BIOMARKERS FOR RENAL DISEASE | July 2009 | November 2012 | Allow | 40 | 1 | 1 | Yes | No |
| 12498183 | TIVOZANIB RESPONSE PREDICTION | July 2009 | August 2009 | Allow | 2 | 0 | 0 | No | No |
| 12496390 | METHOD FOR DETECTING AND QUANTIFYING RARE MUTATIONS/POLYMORPHISMS | July 2009 | December 2011 | Allow | 30 | 1 | 0 | No | No |
| 12439515 | DNA FRAGMENT USED AS ATTACHED TO 5' END OF PRIMER USED IN NUCLEIC ACID AMPLIFICATION REACTION AND USE OF DNA FRAGMENT | February 2009 | August 2011 | Abandon | 30 | 3 | 1 | No | No |
| 12394993 | SPERM CELL SEPARATION METHODS AND COMPOSITIONS CONTAINING APTAMERS OR NUCLEIC ACID SEQUENCES FOR USE THEREIN | February 2009 | November 2011 | Allow | 32 | 1 | 1 | Yes | No |
| 12357995 | UNIFORM FRAGMENTATION OF DNA USING BINDING PROTEINS | January 2009 | April 2012 | Allow | 39 | 3 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WOOLWINE, SAMUEL C.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner WOOLWINE, SAMUEL C works in Art Unit 1681 and has examined 169 patent applications in our dataset. With an allowance rate of 89.3%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 40 months.
Examiner WOOLWINE, SAMUEL C's allowance rate of 89.3% places them in the 69% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by WOOLWINE, SAMUEL C receive 2.33 office actions before reaching final disposition. This places the examiner in the 80% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by WOOLWINE, SAMUEL C is 40 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +5.2% benefit to allowance rate for applications examined by WOOLWINE, SAMUEL C. This interview benefit is in the 30% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 29.6% of applications are subsequently allowed. This success rate is in the 48% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 45.5% of cases where such amendments are filed. This entry rate is in the 63% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 1% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 86% percentile among all examiners. Of these withdrawals, 93.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 65.2% are granted (fully or in part). This grant rate is in the 82% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 20.7% of allowed cases (in the 99% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 15.9% of allowed cases (in the 91% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.